Clarkston Capital Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-12,776
Closed -$2.8M 184
2021
Q1
$2.8M Buy
+12,776
New +$2.56M 0.05% 52
2020
Q2
Sell
-2,153
Closed -$234K 116
2020
Q1
$234K Buy
+2,153
New +$310K 0.01% 88
2014
Q4
Sell
-48,609
Closed -$4.25M 183
2014
Q3
$4.25M Buy
48,609
+4,499
+10% +$406K 0.73% 45
2014
Q2
$3.88M Buy
+44,110
New +$3.82M 0.71% 47

Other funds holding LH

Clarkston Capital Partners's LH Position: Q2 2021 in Review

Clarkston Capital Partners sold out of Labcorp (LH) in Q2 2021, closing a stake of 12,776 shares — an estimated $2.8M sold.

Clarkston Capital Partners first reported a position in LH in Q2 2014 and held it in 4 quarters. The position peaked at $4.25M in Q3 2014. 949 funds tracked by Wall St. Rank hold LH as of Q2 2021.

  • Clarkston Capital Partners reported no remaining Labcorp position as of Q2 2021 after selling out during the quarter.
  • Clarkston Capital Partners sold 12,776 Labcorp shares in Q2 2021, an estimated $2.8M.
  • Clarkston Capital Partners first reported a position in Labcorp in Q2 2014 and held it in 4 quarters.
  • Clarkston Capital Partners's Labcorp position peaked at $4.25M in Q3 2014.
  • 949 funds tracked by Wall St. Rank held Labcorp as of Q2 2021.

Based on Clarkston Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.